As shown in Figure 2A, CCNB1IP1 expression was positively associated with the unfavourable class (poor treatment responsiveness), high‐risk grade, disease‐related death and MYCN amplification status in NB patients. This evidence concerns the gene CCNB1IP1 and neuroblastoma.